EUVIMEDOdkrijte EUVIMED
CrossrefInformacijska kartica

Controversies in renal anemia management

Onyekachi Ifudu

Dialysis & Transplantation · 2006

DOI: 10.1002/dat.20006 ↗
PovzetekBibliografski podatki

Povzetek

Abstract Anemia plays a key role in generating excess cardiovascular morbidity and mortality in patients with chronic kidney disease. Among patients with end‐stage renal disease, low hemoglobin levels contribute to an increased rate of hospitalization and shortened survival. Several issues in the pathogenesis and management of renal anemia, including the use of recombinant erythropoietin, are controversial and unresolved. In addition, the management of anemia has major economic implications. Clarifying these issues ultimately could enhance patient outcomes while lessening the need for erythropoietin and intravenous iron, which could potentially save millions of dollars.

Znanje, ki ustreza vašemu delu.

Od brezplačnega začetka in osebnega iskanja literature do celotnega paketa Research Suite.

Ogled tarif →

Ali so vključena vsa polna besedila založnikov?

Ne. Bibliografski zapisi, povzetki in celotna besedila so različne vsebine. Ali je celotno besedilo na voljo, je odvisno od vira, odprtega dostopa in vaših obstoječih licenc. Paket EUVIMED ne nadomešča dodatnih pravic založnikov.

Ogled tarif →